(1) An individual with a medical cannabis card:

lawyer at desk

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

Terms Used In Utah Code 26B-4-245

  • Cannabis: means marijuana. See Utah Code 26B-4-201
  • Cannabis product: means a product that:
         (8)(a) is intended for human use; and
         (8)(b) contains cannabis or any tetrahydrocannabinol or THC analog in a total concentration of 0. See Utah Code 26B-4-201
  • Department: means the Department of Health and Human Services. See Utah Code 26B-4-201
  • Directions of use: means recommended routes of administration for a medical cannabis treatment and suggested usage guidelines. See Utah Code 26B-4-201
  • Dosing guidelines: means a quantity range and frequency of administration for a recommended treatment of medical cannabis. See Utah Code 26B-4-201
  • Legal dosage limit: means an amount that:
         (22)(a) is sufficient to provide 30 days of treatment based on the dosing guidelines that the relevant recommending medical provider or the state central patient portal or pharmacy medical provider, in accordance with Subsection 26B-4-230(5), recommends; and
         (22)(b) may not exceed:
              (22)(b)(i) for unprocessed cannabis in a medicinal dosage form, 113 grams by weight; and
              (22)(b)(ii) for a cannabis product in a medicinal dosage form, a quantity that contains, in total, greater than 20 grams of active tetrahydrocannabinol. See Utah Code 26B-4-201
  • Medical cannabis: means cannabis in a medicinal dosage form or a cannabis product in a medicinal dosage form. See Utah Code 26B-4-201
  • Medical cannabis cardholder: means :
         (28)(a) a holder of a medical cannabis card; or
         (28)(b) a facility or assigned employee, described in Subsection (16)(b), only:
              (28)(b)(i) within the scope of the facility's or assigned employee's performance of the role of a medical cannabis patient cardholder's caregiver designation under Subsection 26B-4-214(1)(b); and
              (28)(b)(ii) while in possession of documentation that establishes:
                   (28)(b)(ii)(A) a caregiver designation described in Subsection 26B-4-214(1)(b);
                   (28)(b)(ii)(B) the identity of the individual presenting the documentation; and
                   (28)(b)(ii)(C) the relation of the individual presenting the documentation to the caregiver designation. See Utah Code 26B-4-201
  • Medicinal dosage form: includes a portion of unprocessed cannabis flower that:
              (39)(b)(i) the medical cannabis cardholder has recently removed from the container described in Subsection (39)(a)(ii) for use; and
              (39)(b)(ii) does not exceed the quantity described in Subsection (39)(a)(ii). See Utah Code 26B-4-201
  • Pharmacy medical provider: means the medical provider required to be on site at a medical cannabis pharmacy under Section 26B-4-219. See Utah Code 26B-4-201
  • Qualified medical provider: means an individual:
         (43)(a) who meets the recommending qualifications; and
         (43)(b) whom the department registers to recommend treatment with cannabis in a medicinal dosage form under Section 26B-4-204. See Utah Code 26B-4-201
  • Recommending medical provider: means a qualified medical provider or a limited medical provider. See Utah Code 26B-4-201
     (1)(a) may purchase, in any one 28-day period, up to the legal dosage limit of:

          (1)(a)(i) unprocessed cannabis in a medicinal dosage form; and
          (1)(a)(ii) a cannabis product in a medicinal dosage form;
     (1)(b) may not purchase:

          (1)(b)(i) except as provided in Subsection (2), more medical cannabis than described in Subsection (1)(a); or
          (1)(b)(ii) if the relevant recommending medical provider did not recommend directions of use and dosing guidelines, until the individual consults with the pharmacy medical provider in accordance with Subsection 26B-4-231(5), any medical cannabis; and
     (1)(c) may not use a route of administration that the relevant recommending medical provider or the pharmacy medical provider, in accordance with Subsection 26B-4-231(5), has not recommended.
(2)

     (2)(a) A qualified medical provider may petition the department to waive the 28-day period limit described in Subsection (1)(a) for a medical cannabis cardholder if the medical cannabis cardholder:

          (2)(a)(i) has been diagnosed with a terminal illness;
          (2)(a)(ii) has a life expectancy of six months or less; and
          (2)(a)(iii) needs the waiver for palliative purposes.
     (2)(b) The department shall:

          (2)(b)(i) consult with the Compassionate Use Board to determine whether the waiver should be granted;
          (2)(b)(ii) issue a response to the petition within 10 days from the day on which the petition is received.
     (2)(c) The department may waive the 28-day period limit for no more than 180 days.
     (2)(d) A petition described in this Subsection (2) may be combined with the petition described in Subsection 26B-1-421(6).
  Previous section
Next section  
 Part 2 Contents